Dr. Vanessa Rodríguez Fanjul

Dr. Vanessa Rodríguez Fanjul graduated in Biochemistry from Universidad Autónoma de Madrid (Spain) in 2004. She obtained a PhD in Biochemistry, Molecular Biology and Biomedicine from the same University in 2011 developing her work at the Spanish Research Council (CSIC). She investigated the role of MKP1 protein on carcinogenesis and on the response to carboplatin (CBDCA) of lung and skin cancer by using both, cellular and animal models. In 2013 she joined IMDEA Nanociencia as a Postdoctoral fellow where she studied the cytotoxicity, uptake and distribution mechanisms of magnetic nanoparticles in various cell lines and cancer stem cells from human glioblastoma multiforme (GBM). Currently, she is a post-doctoral researcher in the Laboratory of Metallodrugs at IMDEA Nanociencia, studying the cytotoxic effect and molecular targets (including the mechanism of action) of different metal complexes of Ru, Rh, Os, Ir, Pt and Au.